Tyra Biosciences (TYRA) Change in Acquisitions & Divestments (2024 - 2026)

Tyra Biosciences (TYRA) has 3 years of Change in Acquisitions & Divestments data on file, last reported at $42.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments rose 8.07% year-over-year to $42.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $177.0 million (up 1.26% YoY) and the FY2025 annual result came in at $173.9 million, up 4.81% from the prior year.
• Change in Acquisitions & Divestments retreated to $42.0 million in Q1 2026, from $43.5 million in the prior quarter.
• In the past five years, Change in Acquisitions & Divestments ranged from a high of $58.0 million in Q3 2024 to a low of $30.0 million in Q1 2024.
• A 3-year average of $42.4 million and a median of $42.0 million in 2026 frame the typical range for Change in Acquisitions & Divestments.
• The widest YoY moves for Change in Acquisitions & Divestments: up 29.7% in 2025, down 13.09% in 2025.
• Tracing TYRA's Change in Acquisitions & Divestments over 3 years: stood at $45.0 million in 2024, then declined by 3.24% to $43.5 million in 2025, then decreased by 3.42% to $42.0 million in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $42.0 million (Q1 2026), $43.5 million (Q4 2025), and $50.4 million (Q3 2025), per Business Quant data.